{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:02:48Z","timestamp":1792526568909,"version":"4.5.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,5,2]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Implantation failure remains a critical barrier to in vitro fertilization. Prednisone, as an immune-regulatory agent, is widely used to improve the probability of implantation and pregnancy, although the evidence for efficacy is inadequate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the efficacy of 10 mg of prednisone compared with placebo on live birth among women with recurrent implantation failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>A double-blind, placebo-controlled, randomized clinical trial conducted at 8 fertility centers in China. Eligible women who had a history of 2 or more unsuccessful embryo transfer cycles, were younger than 38 years when oocytes were retrieved, and were planning to undergo frozen-thawed embryo transfer with the availability of good-quality embryos were enrolled from November 2018 to August 2020 (final follow-up August 2021).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Participants were randomized (1:1) to receive oral pills containing either 10 mg of prednisone (n\u2009=\u2009357) or matching placebo (n\u2009=\u2009358) once daily, from the day at which they started endometrial preparation for frozen-thawed embryo transfer through early pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was live birth, defined as the delivery of any number of neonates born at 28 or more weeks\u2019 gestation with signs of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 715 women randomized (mean age, 32 years), 714 (99.9%) had data available on live birth outcomes and were included in the primary analysis. Live birth occurred among 37.8% of women (135 of 357) in the prednisone group vs 38.8% of women (139 of 358) in the placebo group (absolute difference, \u22121.0% [95% CI, \u22128.1% to 6.1%]; relative ratio [RR], 0.97 [95% CI, 0.81 to 1.17];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.78). The rates of biochemical pregnancy loss were 17.3% in the prednisone group and 9.9% in the placebo group (absolute difference, 7.5% [95% CI, 0.6% to 14.3%]; RR, 1.75 [95% CI, 1.03 to 2.99];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.04). Of those in the prednisone group, preterm delivery occurred among 11.8% and of those in the placebo group, 5.5% of pregnancies (absolute difference, 6.3% [95% CI, 0.2% to 12.4%]; RR, 2.14 [95% CI, 1.00 to 4.58];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.04). There were no statistically significant between-group differences in the rates of biochemical pregnancy, clinical pregnancy, implantation, neonatal complications, congenital anomalies, other adverse events, or mean birthweights.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Among patients with recurrent implantation failure, treatment with prednisone did not improve live birth rate compared with placebo. Data suggested that the use of prednisone may increase the risk of preterm delivery and biochemical pregnancy loss. Our results challenge the value of prednisone use in clinical practice for the treatment of recurrent implantation failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      Chinese Clinical Trial Registry Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.chictr.org.cn\/showproj.aspx?proj=31155\">ChiCTR1800018783<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2023.5302","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T11:09:58Z","timestamp":1683025798000},"page":"1460","source":"Crossref","is-referenced-by-count":72,"title":["Prednisone vs Placebo and Live Birth in Patients With Recurrent Implantation Failure Undergoing In Vitro Fertilization"],"prefix":"10.1001","volume":"329","author":[{"given":"Yun","family":"Sun","sequence":"first","affiliation":[{"name":"Center for Reproductive Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Cui","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Shandong University, Jinan, China"},{"name":"Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, China"},{"name":"Shandong Key Laboratory of Reproductive Medicine, Jinan, China"},{"name":"Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, China"},{"name":"Shandong Technology Innovation Center for Reproductive Health, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichun","family":"Tan","sequence":"additional","affiliation":[{"name":"Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China"},{"name":"Key Laboratory of Reproductive Dysfunction Diseases and Fertility Remodeling of Liaoning Province, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Dong","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiang","family":"Ni","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Shandong University, Jinan, China"},{"name":"Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, China"},{"name":"Shandong Key Laboratory of Reproductive Medicine, Jinan, China"},{"name":"Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, China"},{"name":"Shandong Technology Innovation Center for Reproductive Health, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Yan","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Shandong University, Jinan, China"},{"name":"Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, China"},{"name":"Shandong Key Laboratory of Reproductive Medicine, Jinan, China"},{"name":"Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, China"},{"name":"Shandong Technology Innovation Center for Reproductive Health, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichun","family":"Guan","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guimin","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, the Second Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, the First Affiliated Hospital of Nanjing Medical University\/Jiangsu Province Hospital, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Maternal and Child Health Hospital\/Obstetrics and Gynecology Hospital of Guangxi Zhuang Autonomous Region, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daimin","family":"Wei","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Shandong University, Jinan, China"},{"name":"Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, China"},{"name":"Shandong Key Laboratory of Reproductive Medicine, Jinan, China"},{"name":"Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, China"},{"name":"Shandong Technology Innovation Center for Reproductive Health, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Hong","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiong","family":"He","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Qi","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xu","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Lu","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Shandong University, Jinan, China"},{"name":"Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, China"},{"name":"Shandong Key Laboratory of Reproductive Medicine, Jinan, China"},{"name":"Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, China"},{"name":"Shandong Technology Innovation Center for Reproductive Health, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Shandong University, Jinan, China"},{"name":"Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, China"},{"name":"Shandong Key Laboratory of Reproductive Medicine, Jinan, China"},{"name":"Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, China"},{"name":"Shandong Technology Innovation Center for Reproductive Health, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Center of Reproductive Medicine, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China"},{"name":"Key Laboratory of Reproductive Dysfunction Diseases and Fertility Remodeling of Liaoning Province, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Ji","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Du","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, the Second Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, the First Affiliated Hospital of Nanjing Medical University\/Jiangsu Province Hospital, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, the First Affiliated Hospital of Nanjing Medical University\/Jiangsu Province Hospital, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqin","family":"Huang","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Maternal and Child Health Hospital\/Obstetrics and Gynecology Hospital of Guangxi Zhuang Autonomous Region, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Huang","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Maternal and Child Health Hospital\/Obstetrics and Gynecology Hospital of Guangxi Zhuang Autonomous Region, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhi","family":"Du","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Vankelecom","sequence":"additional","affiliation":[{"name":"Laboratory of Tissue Plasticity in Health and Disease, Cluster of Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-jiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China"},{"name":"Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, China"},{"name":"Center for Reproductive Medicine, Shandong University, Jinan, China"},{"name":"Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, China"},{"name":"Shandong Key Laboratory of Reproductive Medicine, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"joi230041r1","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1093\/humrep\/deaa250","article-title":"20 years of the European IVF-monitoring consortium registry: what have we learned? a comparison with registries from two other regions.","volume":"35","author":"De Geyter","year":"2020","journal-title":"Hum Reprod"},{"issue":"2","key":"joi230041r2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/humrep\/dez245","article-title":"Assisted reproductive technology service availability, efficacy and safety in mainland China: 2016.","volume":"35","author":"Bai","year":"2020","journal-title":"Hum Reprod"},{"issue":"10178","key":"joi230041r3","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/S0140-6736(18)32843-5","article-title":"Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial.","volume":"393","author":"Wei","year":"2019","journal-title":"Lancet"},{"issue":"10038","key":"joi230041r4","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1016\/S0140-6736(16)00258-0","article-title":"Hysteroscopy in Recurrent In-Vitro Fertilisation Failure (TROPHY): a multicentre, randomised controlled trial.","volume":"387","author":"El-Toukhy","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"joi230041r5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1056\/NEJMoa1705334","article-title":"Transfer of fresh versus frozen embryos in ovulatory women.","volume":"378","author":"Shi","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"joi230041r6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12958-018-0414-2","article-title":"Recurrent implantation failure\u2014update overview on etiology, diagnosis, treatment and future directions.","volume":"16","author":"Bashiri","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"issue":"5","key":"joi230041r7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.rbmo.2020.08.007","article-title":"Recurrent implantation failure in IVF: a Canadian Fertility and Andrology Society clinical practice guideline.","volume":"41","author":"Shaulov","year":"2020","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"joi230041r8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/14647273.2021.1905886","article-title":"Management of recurrent implantation failure: British Fertility Society policy and practice guideline.","volume":"25","author":"Mascarenhas","year":"2022","journal-title":"Hum Fertil (Camb)"},{"key":"joi230041r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2021.103369","article-title":"Reproductive outcomes of women with recurrent pregnancy losses and repeated implantation failures are significantly improved with immunomodulatory treatment.","volume":"148","author":"Sung","year":"2021","journal-title":"J Reprod Immunol"},{"issue":"6","key":"joi230041r10","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.fertnstert.2017.04.009","article-title":"Immune modulation treatments-where is the evidence?","volume":"107","author":"Hviid","year":"2017","journal-title":"Fertil Steril"},{"issue":"2","key":"joi230041r11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/humrep\/deaa317","article-title":"Definition, diagnostic and therapeutic options in recurrent implantation failure: an international survey of clinicians and embryologists.","volume":"36","author":"Cimadomo","year":"2021","journal-title":"Hum Reprod"},{"key":"joi230041r12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jri.2018.03.003","article-title":"Impact of prednisone in patients with repeated embryo implantation failures: beneficial or deleterious?","volume":"127","author":"L\u00e9d\u00e9e","year":"2018","journal-title":"J Reprod Immunol"},{"issue":"2","key":"joi230041r13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/ajo.v62.2","article-title":"A survey study of endometrial receptivity tests and immunological treatments in in vitro fertilisation (IVF).","volume":"62","author":"Kieu","year":"2022","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"3","key":"joi230041r14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.fertnstert.2018.05.009","article-title":"The role of immunotherapy in in vitro fertilization: a guideline.","volume":"110","author":"Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org","year":"2018","journal-title":"Fertil Steril"},{"issue":"5","key":"joi230041r15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/humupd\/dmn021","article-title":"Potential significance of physiological and pharmacological glucocorticoids in early pregnancy.","volume":"14","author":"Michael","year":"2008","journal-title":"Hum Reprod Update"},{"issue":"9","key":"joi230041r16","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/jcph.v58.9","article-title":"Prednisone pharmacokinetics during pregnancy and lactation.","volume":"58","author":"Ryu","year":"2018","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"joi230041r17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/09513590.2017.1380182","article-title":"Administration of prednisolone and low molecular weight heparin in patients with repeated implantation failures: a cohort study.","volume":"34","author":"Siristatidis","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"joi230041r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2021.103313","article-title":"Unexplained recurrent implantation failures: predictive factors of pregnancy and therapeutic management from a French multicentre study.","volume":"145","author":"Kolanska","year":"2021","journal-title":"J Reprod Immunol"},{"issue":"6","key":"joi230041r19","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.fertnstert.2014.08.029","article-title":"Immunomodulatory treatment with intravenous immunoglobulin and prednisone in patients with recurrent miscarriage and implantation failure after in vitro fertilization\/intracytoplasmic sperm injection.","volume":"102","author":"Nyborg","year":"2014","journal-title":"Fertil Steril"},{"issue":"3","key":"joi230041r20","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00404-013-3020-8","article-title":"Does combined prednisolone and low molecular weight heparin have a role in unexplained implantation failure?","volume":"289","author":"Fawzy","year":"2014","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"joi230041r21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/aji.12559","article-title":"Combined treatment of prednisone and aspirin, starting before ovulation induction, may improve reproductive outcomes in ANA-positive patients.","volume":"76","author":"Fan","year":"2016","journal-title":"Am J Reprod Immunol"},{"issue":"6","key":"joi230041r22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005996.pub4","article-title":"Peri-implantation glucocorticoid administration for assisted reproductive technology cycles.","volume":"6","author":"Boomsma","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"joi230041r23","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1186\/s13063-020-04630-6","article-title":"Prednisone for patients with recurrent implantation failure: study protocol for a double-blind, multicenter, randomized, placebo-controlled trial.","volume":"21","author":"Lu","year":"2020","journal-title":"Trials"},{"issue":"3","key":"joi230041r24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009517.pub3","article-title":"Endometrial injury in women undergoing assisted reproductive techniques.","author":"Nastri","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"joi230041r25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/humupd\/dmy034","article-title":"The impact of intentional endometrial injury on reproductive outcomes: a systematic review and meta-analysis.","volume":"25","author":"Sar-Shalom Nahshon","year":"2019","journal-title":"Hum Reprod Update"},{"issue":"24","key":"joi230041r26","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1001\/jama.2015.17296","article-title":"Live-Birth rate associated with repeat in vitro fertilization treatment cycles.","volume":"314","author":"Smith","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"joi230041r27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1056\/NEJM199707173370302","article-title":"Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss.","volume":"337","author":"Laskin","year":"1997","journal-title":"N Engl J Med"},{"issue":"4","key":"joi230041r28","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1210\/en.2018-01039","article-title":"Maternal glucocorticoids make the fetal membrane thinner: involvement of amniotic macrophages.","volume":"160","author":"Kiyokawa","year":"2019","journal-title":"Endocrinology"},{"issue":"1","key":"joi230041r29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jaip.2020.07.047","article-title":"Oral corticosteroids and risk of preterm birth in the California Medicaid program.","volume":"9","author":"Palmsten","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"joi230041r30","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/rheumatology\/kez405","article-title":"Oral corticosteroid use during pregnancy and risk of preterm birth.","volume":"59","author":"Palmsten","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"joi230041r31","article-title":"Interventions for treating hyperemesis gravidarum.","author":"Boelig","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"13","key":"joi230041r32","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/jama.2016.14337","article-title":"Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review.","volume":"316","author":"McParlin","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"joi230041r33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.fertnstert.2019.12.009","article-title":"Vitrification of the human embryo: a more efficient and safer in vitro fertilization treatment.","volume":"113","author":"Nagy","year":"2020","journal-title":"Fertil Steril"},{"issue":"21","key":"joi230041r34","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1001\/jama.2022.20438","article-title":"Effect of timing by endometrial receptivity testing vs standard timing of frozen embryo transfer on live birth in patients undergoing in vitro fertilization: a randomized clinical trial.","volume":"328","author":"Doyle","year":"2022","journal-title":"JAMA"},{"key":"joi230041r35","doi-asserted-by":"publisher","first-page":"j895","DOI":"10.1136\/bmj.j895","article-title":"Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study.","volume":"356","author":"Desai","year":"2017","journal-title":"BMJ"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2804325\/jama_sun_2023_oi_230041_1682611584.21728.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T11:10:03Z","timestamp":1683025803000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2804325"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":35,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2023,5,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.5302","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,2]]}}}